Can a common bone drug help HIV patients? new trial finds out
NCT ID NCT00120757
First seen Apr 09, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study tested whether alendronate, a drug used for osteoporosis, can improve bone density in people with HIV. 140 participants received either alendronate or a placebo, along with calcium and vitamin D, for 2 years. The main goal was to measure changes in bone density in the spine and hip.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker service des Maladies Infectieuses
Paris, 75015, France
-
Service de Medecine Interne hopital Avicenne
Bobigny, 93009 cedex, France
-
Service de Rhumatologie hopital Pitie-Salpetriere
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.